WATCH TIME: 3 minutes| Captions are auto-generated and may contain errors.
“In addition to [the positive safety data], we are looking at various mechanistic biomarkers which will tell us whether this drug works the same way in humans and people…
Jonas Hannestad, MD, PhD: Phase 1b Interim Data on GT-02287 in Parkinson Disease | NeurologyLive
